Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. Kutluk Cenik
BIBF 1120 (Nintedanib), a Triple Angiokinase Inhibitor, Induces Hypoxia but Not EMT and Blocks Progression of Preclinical Models of Lung and Pancreatic Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
BIBF 1120/Nintedanib: A New Triple Angiokinase Inhibitor-Directed Therapy in Patients With Non-Small Cell Lung Cancer
Expert Opinion on Investigational Drugs
Medicine
Pharmacology
Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker in Vivo
Clinical Cancer Research
Cancer Research
Oncology
EMT: A New Vision of Hypoxia Promoting Cancer Progression
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Characterization of Triple-Negative Breast Cancer Preclinical Models Provides Functional Evidence of Metastatic Progression
International Journal of Cancer
Cancer Research
Oncology
A Phase II Evaluation of Nintedanib (BIBF-1120) in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
The Gamma Secretase Inhibitor MRK-003 Attenuates Pancreatic Cancer Growth in Preclinical Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Inhibition of StearoylCoA Desaturase Activity Blocks Cell Cycle Progression and Induces Programmed Cell Death in Lung Cancer Cells
PLoS ONE
Multidisciplinary
Nintedanib Inhibits Fibroblast Activation and Ameliorates Fibrosis in Preclinical Models of Systemic Sclerosis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
GEMMs as Preclinical Models for Testing Pancreatic Cancer Therapies
DMM Disease Models and Mechanisms
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
